Serdemetan

TargetMol
Product Code: TAR-T2243
Supplier: TargetMol
CodeSizePrice
TAR-T2243-2mg2mg£102.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T2243-5mg5mg£122.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T2243-1mL1 mL * 10 mM (in DMSO)£127.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T2243-10mg10mg£148.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T2243-25mg25mg£230.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T2243-50mg50mg£369.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T2243-100mg100mg£517.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T2243-500mg500mg£1,050.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT

Overview

Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃

Images

1 / 1

Further Information

Bioactivity:
Serdemetan is an orally bioavailable HDM2 antagonist with potential antineoplastic activity.
CAS:
881202-45-5
Formula:
C21H20N4
Molecular Weight:
328.419
Pathway:
Ubiquitination; Apoptosis
Purity:
0.98
SMILES:
C(Cc1c[nH]c2ccccc12)Nc1ccc(Nc2ccncc2)cc1
Target:
Apoptosis; Mdm2; E1/E2/E3 Enzyme; p53

References

1. Kojima K, et al. Mol Cancer Ther. 2010, 9(9), 2545-2557. 2. Yuan Y, et al. J Hematol Oncol. 2011, 4:16. 3. Chargari C, et al. Cancer Lett. 2011, 312(2), 209-218. 4. Smith MA, et al. Pediatr Blood Cancer, 2012, 59(2), 329-332. 5. Liu Z, Chen Y, Gao H, et al. Berberine Inhibits Cell Proliferation by Interfering with Wild-Type and Mutant P53 in Human Glioma Cells[J]. OncoTargets and Therapy . 2020, 13: 12151-12162.